AI-generated summary
The authors tested LED light at four wavelengths on chondrocytes in vitro and on DMM-induced knee osteoarthritis mice in vivo. They report that 940 nm at 52 J/cm2 best suppressed cartilage-degrading markers, improved weight-bearing asymmetry, and reduced cartilage damage. The findings come from cell and mouse models, so clinical relevance is not established.
- Who or what was studied
- Murine knee osteoarthritis model (DMM-induced mice, n = 5-6 per group) and TNF-α-stimulated RCJ 3.1.C5.18 chondrocytes in vitro
- Wavelengths
- 625, 810, 940, 1050 nm
- Limits stated in the abstract
- Findings come from in vitro cell culture and a small murine model with 5-6 animals per group, so clinical translation is not established.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Photobiomodulation using light-emitting diode (LED) therapy is a promising and safe non-invasive approach for treating knee osteoarthritis (KOA), yet the most effective wavelength and energy density to prevent cartilage matrix degradation remain unclear. This study aimed to determine the optimal LED parameters for suppressing chondrocyte extracellular matrix (ECM) degradation in vitro, and for alleviating ECM degradation and pain-related behaviours in a murine KOA model.
Methods
TNF-α-stimulated RCJ 3.1.C5.18 chondrocytes were irradiated with LEDs (625/810/940/1050 nm; 13-78 J/cm2 at 44 mW/cm2). Chondrocyte ECM-related markers (mmp3, mmp13, col2a1, aggrecan) were quantified via RT-qPCR. In vivo, destabilization of the medial meniscus (DMM)-induced KOA mice (n = 5-6/group) received 810 nm (39/52 J/cm2) or 940 nm (39/52 J/cm2) LED therapy thrice weekly for 6 weeks. Pain-like behaviors (Von Frey, incapacitance tests) and histopathology (OARSI scoring, mmp3/collagen II immunofluorescence) were assessed.
Results
In vitro, 940 nm LED at 52 J/cm2 most effectively suppressed mmp3/mmp13 mRNA (P < 0.05) and upregulated col2a1/aggrecan (P < 0.05), while 810 nm at 39 J/cm2 only inhibited mmp3 and mmp13. The LED with 625 nm and 1050 nm showed no significant effect on chondrocyte ECM degradation markers. In vivo, 940 nm at 52 J/cm2 improved weight-bearing asymmetry by 31% at 6 weeks (vs. DMM controls, P = 0.03) and reduced cartilage degradation by 50% (OARSI score, P = 0.03). Immunofluorescence indicated that 940 nm at 52 J/cm2 LED therapy significantly inhibited the expression of mmp3 and increased collagen II protein levels in cartilage tissues.
Conclusion
LED therapy at 940 nm with 52 J/cm2 attenuates ECM degradation and pain in KOA, defining a target LED parameter set for potential clinical translation.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1050 nm, 810 nm, 940 nm, 625 nm
- Energy density (fluence)
- 78 J/cm2, 52 J/cm2, 39 J/cm2
- Power density (irradiance)
- 44 mW/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Photobiomodulation, Osteoarthritis, Collagen, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.